Skip to main content
  1. Right Decisions
  2. Back
  3. Breast pathways (referral pathways)
  4. Breast pain pathway update
Announcements and latest updates

Right Decision Service newsletter: April 2024

Welcome to the Right Decision Service (RDS) newsletter for April 2024. 

Issues with RDS and Umbraco access

Tactuum has been working hard to address the issues experienced during the last week. They have identified a series of three mitigation measures and put the first of these in place on Friday 3rd May.  If this does not resolve the problems, the second mitigation will be actioned, and then the third if necessary.

Please keep a lookout for any slowing down of the system or getting locked out. Please email myself, mbuchner@tactuum.com and onivarova@tactuum.com if you experience any problems, and also please raise an urgent support ticket via the Support Portal.

Thank you for your patience and understanding while we achieve a full resolution.

Promotion and communication resources

A rotating carousel presenting some of the key RDS tools and capabilities, and an editable slideset, are now available in the Resources for RDS providers section of the Learning and Support toolkit.

Redesign and improvements to RDS

The redesign of RDS Search and Browse is still on-track for delivery by mid-June 2024. We then plan to have a 3-week user acceptance testing phase before release to live. All editors and toolkit owners on this mailing list will be invited to participate in the UAT.

The archiving and version control functionality is also progressing well and we will advise on timescales for user acceptance testing shortly.

Tactuum is also progressing with the deep linking to individual toolkits within the mobile RDS app. There are several unknowns around the time and effort required for this work, which will only become clear as the work progresses. So we need to be careful to protect budget for this purpose.

New feature requests

These have all been compiled and effort estimated. Once the redesign work is complete, these will be prioritised in line with the remaining budget. We expect this to take place around late June.

Evaluation

Many thanks to those of you completed the value and impact survey we distributed in February. Here are some key findings from the 65 responses we received.

Figure 1: Impact of RDS on direct delivery of care

Key figures

  • 93% say that RDS has improved evidence-informed practice (high impact 62%; some impact 31%)
  • 91% report that RDS has improved consistency in practice (high impact 65%, some impact 26%)
  • 85% say that RDS has improved patient safety (high impact 59%, some impact 26%)
  • Although shared decision-making tools are only a recent addition to RDS, and only represent a small proportion of the current toolset, 85% of respondents still said that RDS had delivered impact in this area (53% high impact, 32% some impact.) 92% anticipate that RDS will deliver impact on shared decision-making in future and 85% believe it will improve delivery of personalised care in future.

Figure 2 shows RDS impact to date on delivery of health and care services

 

Key figures

These data show how RDS is already contributing to NHS reform priorities and supporting delivery of more sustainable care.

Saving time and money

  • RDS clearly has a strong impact on saving practitioner time, with 90% of respondents reporting that this is the case. 65% say it has a high impact; 25% say it has some impact on time-saving.
  • It supports devolved decision-making across the multi-professional team (85% of respondents)
  • 76% of respondents confirm that it saves money compared, for example, to investing in commercial apps (54% high impact; 22% some impact.)
  • 72% believe it has impacted already on saving money and reducing waste in the way services are delivered – e.g. reducing costs of referral management, prescribing, admissions.

Quality assurance and governance

  • RDS leads are clear that RDS has improved local governance of guidelines, with 87% confirming that this is the case. (62% high impact; 25% some impact.)

Service innovation and workforce development

  • RDS is a major driver for service innovation and improvement (83% of respondents) and has impacted significantly on workforce knowledge and skills (92% of respondents – 66% high impact; 26% some impact).

New toolkits

A few examples of toolkits published to live in the last month:

Toolkits in development

Some of the toolkits the RDS team is currently working on:

  • SARCS (Sexual Assault Response Coordination Service)
  • Staffing method framework – Care Inspectorate.
  • SIGN 171 - Diabetes in pregnancy
  • SIGN 158 – British Guideline on Management of Asthma. Selected sections will be incorporated into the RDS, and complemented by a new chronic asthma pathway being developed by SIGN, British Thoracic Society and NICE.
  • Clinical pathways from NHS Fife and NHS Lanarkshire

Please contact his.decisionsupport@nhs.scot if you would like to learn more about a toolkit. The RDS team will put you in touch with the relevant toolkit lead.

Quality audit of RDS toolkits

Thanks to all of you who have responded to the retrospective quality audit survey and to the follow up questions.  We still have some following up to do, and to work with owners of a further 23 toolkits to complete responses. An interim report is being presented to the HIS Quality and Performance Committee.

Implementation projects

Eight clinical services and two public library services are undertaking tests of change to implement the Being a partner in my care app. This app aims to support patients and the public to become active participants in Realistic Medicine. It has a strong focus on personalised, person-centred care and a library of shared decision aids, as well as simple explanations and videoclips to help the public to understand the aims of Realistic Medicine.  The tests of change will inform guidance and an implementation model around wider adoption and spread of the app.

With kind regards

Right Decision Service team

Healthcare Improvement Scotland

Breast pain pathway update

The Symptomatic Breast Pain Specialty Delivery Group published the Breast Pain Pathway in 2022.

While breast pain accounts for 15% of all clinical referrals, almost all people who are referred with breast/axillary pain have chest wall pain unrelated to the breast itself.

The pathway covers advice for healthcare professionals in relation to the following:

  • Imaging for Breast Pain (based on best available evidence)
  • Referral to Secondary Care
  • Management of patients with breast pain within primary care

Click the play button below to find out more about breast pain.

 

Remit

In 2019 the Scottish Access Collaborative Development Group (Breast) met to discuss themes that could be developed to sustainably improve waiting times for non-urgent care within breast services.

This work has been progressed through the Modernising Patient Pathways Programme Symptomatic Breast Group to focus on delivering services in an effective, patient-centred way and is based on the NICE clinical knowledge summary (CKS) on cyclical breast pain.1

The recommendations have not followed the standard process used by SIGN to develop guidelines. They are based on available guidance and expert opinion, with fast peer review as assurance.

This guidance will be reviewed and updated as new evidence emerges.

 

Recommendations

A common theme during these meetings has been a focus on the referral of breast pain to secondary care services. A consensus was formed around two principles that:

  1. There has been an increasing medicalisation of the symptom of breast pain, despite this being usually an entirely normal physiological process. Breast pain is the main factor in around 15% of all symptomatic breast clinic referrals leading to over investigation.
  2. Almost all people who are referred with breast/axillary pain have chest wall pain unrelated to the breast itself.

The Modernising Patient Pathway Programme Symptomatic Breast Group was tasked to discuss current and proposed practice and to develop recommendations for the management of people with breast pain. It is important to note that these recommendations are for patients with breast pain only and with no other worrying symptoms or signs on presentation (details of such signs and symptoms are provided in the NICE CKS).1,2

The recommendations fall into three groups:

1.   Imaging for breast pain

Currently there is a widespread difference between, and within, Scottish breast units with regard to imaging patients with breast pain; with some imaging no patients, some all patients and some using it as an opportunity for screening.

We suggest that:

a.   There is no indication for imaging patients with breast pain in the absence of any other symptoms or signs

b.   If patients have missed screening appointments they should be directed to the appropriate screening pathway to be included within a fully quality-assured programme, and opportunistic screening within symptomatic practice is not recommended

c.   If units wish to image patients with breast pain it may be worth auditing this pathway to see if the incidence of cancers differs from an age-matched screening population.

 

2.  Referral to secondary care

a.   We suggest that patients with symptoms of breast pain, whether pre- or postmenopausal, can be reassured that this a normal process, usually settles of its own accord and are directed to symptomatic relief advice. Ideally, this reassurance would be provided through public messaging on NHS and third-sector platforms without necessitating a need to be seen in primary care.3

b.   Patients who are referred to secondary care should:

  • have intractable severe unifocal postmenopausal breast (not chest wall or axillary) pain
  • have had 3 months’ trial of conservative advice management
  • appreciate that further management options, apart from analgesia, are very limited.

c.   The very small number of patients with breast pain requiring referrals to secondary care do not necessarily need to be managed in rapid access clinics but instead could be given:

  • written advice which is also shared with their GP
  • a telephone/Near me appointment with specialist nurses
  • an appointment in a low risk/benign clinic.

 

3.   Management of patients with breast pain within primary care practice

a.   Patients experiencing breast or chest wall pain can be strongly reassured that in the absence of any other symptoms or findings that this is normal, usually self limiting and not linked with malignancy.

b.   Most postmenopausal breast pain is actually chest wall in origin and patients can be reassured accordingly.

c.   Conservative management advice should include a well-fitted supportive bra and regular use of topical NSAIDs massaged into the symptomatic area on the chest wall.

 

Development Group Members

  • Matthew Barber - Consultant Breast Surgeon, NHS Lothian
  • Ian Daltrey - Consultant Breast Surgeon, NHS Highland
  • Mike McKirdy - Consultant Breast Surgeon, NHS Greater Glasgow & Clyde
  • Rachel Meney - Surgical Nurse Practitioner, NHS Greater Glasgow & Clyde
  • Sian Tovey - Consultant Breast Surgeon, NHS Ayrshire and Arran and Chair of the group

 

Editorial Information

Last reviewed: 01/06/2022

Author(s): Symptomatic Breast Speciality Delivery Group.

Version: 2.0

Approved By: Centre for Sustainable Delivery